Daan Gene announced that recently, Guangzhou Datai Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, obtained a medical device registration certificate issued by the State Drug Administration. The name of the medical device is alpha-fetoprotein determination kit, and the registration certificate number is Guozheng 20263401671, which is valid from the date of approval until August 3, 2031. This product is used to quantitatively measure the content of alpha-fetoprotein in human serum and plasma. It is mainly used for primary liver cancer treatment and monitoring. It cannot be used as a basis for early diagnosis or diagnosis of malignant tumors, and is not used for tumor screening in the general population.

Daan Gene announced that recently, Guangzhou Datai Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, obtained a medical device registration certificate issued by the State Drug Administration. The name of the medical device is alpha-fetoprotein determination kit, and the registration certificate number is Guozheng 20263401671, which is valid from the date of approval until August 3, 2031. This product is used to quantitatively measure the content of alpha-fetoprotein in human serum and plasma. It is mainly used for primary liver cancer treatment and monitoring. It cannot be used as a basis for early diagnosis or diagnosis of malignant tumors, and is not used for tumor screening in the general population.